FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to infectious diseases and can be used for prevention of herpes simplex disease recurrence. For this purpose patients in intra-recurrence period are administered complex of measures aimed at reduction of skin and mucosa acidity: special diet, favouring shift of pH of tissues and biological fluids toward alkali side, consumption of 3-4 litres of drinking water a day, limiting consumption of products possessing "acidifying" properties, salt and pickles, exclusion of food vinegar and containing it products from diet. During period of high risk of disease recurrence development additionally perorally administered is 0.25% solution of sodium citrate 100 ml per hour during 10 hours daily. After each two weeks of carrying our anti-recurrence measures 5-7 day recess is administered.
EFFECT: invention allows to increase efficiency of anti-recurrence prophylaxis due to suppression of retraction of herpes simplex viruses and their leaving ganglia nerve cells by reducing skin and mucosa acidity.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
RECURRENT ERYSIPELAS PREVENTION METHOD | 2007 |
|
RU2354144C1 |
METHOD FOR PREDICTION OF RECURRENT DISEASES IN PATIENTS WITH OROFACIAL OR GENITAL HERPES SIMPLEX | 2013 |
|
RU2514654C1 |
METHOD OF CLINICAL NUTRITION OF PATIENTS SUFFERING FROM CHRONIC HEPATITIS C AND BEING ON INTEGRATED ANTIVIRAL THERAPY | 2008 |
|
RU2373952C1 |
METHOD OF PREDICTING INTERFERON-RIVABIRIN-INDUCED NEUROPENIA IN PATIENTS WITH CHRONIC HEPATITIS C OBTAINING COMBINED ANTIVIRAL THERAPY | 2011 |
|
RU2444998C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHRONIC FORM OF HERPES SIMPLEX AND SUBCLINICAL CARRIER STATE OF ANTI-HERPES ANTIBODY | 2013 |
|
RU2516913C1 |
METHOD OF PREDICTING DEVELOPMENT OF NEUTROPENIA, CAUSED BY COMBINED ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2449278C1 |
METHOD FOR PHYSIOTHERAPEUTIC PREVENTION OF RECURRENT DISEASE IN PATIENTS WITH HERPES SIMPLEX | 2018 |
|
RU2693221C1 |
METHOD OF NON-INVASIVE DETERMINATION OF VIRAL STRESS LEVEL IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2468743C2 |
METHOD FOR PREVENTING THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2568593C1 |
METHOD FOR PREVENTION OF ANAEMIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINED ANTIVIRAL THERAPY | 2014 |
|
RU2578409C1 |
Authors
Dates
2009-05-10—Published
2007-11-29—Filed